Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ThoughtFoods Announces that Nootropics are Now Commonplace and What to Consider Before Buying

Thanks to their wide ranging cognitive enhancing properties, nootropics are spreading across all sectors of society and may soon even become as common as coffee. This means that people that are not using them will be left behind.


News provided by

ThoughtFoods

Sep 25, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

ThoughtFoods Nootropics
ThoughtFoods Nootropics
Youtube
Youtube

SAN DIEGO, Sept. 25, 2018 /PRNewswire-PRWeb/ -- Nootropics is a class of compounds that improve cognition, sometimes referred to as "smart drugs". It is used to augment cognitive performance and/or modulate mood in healthy individuals. Cognitive functions that are boosted with nootropics include memory, attention, learning, motivation, creativity and intelligence. Out of all of these brain enhancing benefits, nootropic supplements that are specifically designed to improve memory are the most popular ones. This can be explained by a growing awareness of the potential benefits from memory enhancing nootropics among students and executives.

The global nootropics market is predicted to reach over USD 6 billion by 2024. This clearly shows an expanding usage of nootropics and an ever increasing demand for such brain health supplements. Students, entrepreneurs, investment bankers, scientists, and artists all use nootropics in order to gain competitive mental edge. Silicon Valley is certainly the most developed market for nootropics as there is a high prevalence of "smart pills" users, but the practice appears to be widespread elsewhere too.

iQtropics CEO Kestutis Rasimavicius has a clear vision of iQtonic smart drink starting a new revolution of replacing the traditional energy drinks and becoming a convenient drink for everyone

Post this

For example, the prestigious scientific journal Nature conducted an online pool of its readers about their use of prescription drugs, such as Ritalin and Provigil for neuroenhancement. They found that 20% of the 1400 self-selected readers indicated that had used these drugs for non-medical reasons to stimulate their focus, concentration or memory.

Students are also increasingly taking nootropic supplements instead of Red Bull or triple espressos. A recent survey found that 15% of University of Oxford students take a "study drug" Modafinil to stay competitive and productive. The so-called "study drug", which is a prescription drug used to treat excessive sleeping, has been recently found to have significant cognitive benefits in healthy non-sleep deprived individuals. Such findings have clear practical applications for anyone looking to improve their cognitive functions. The prevalence of nootropic supplements and prescription drugs users among the students in the US universities is very similar to that found in the UK. A 2014 study found that 18% of students from Ivy League colleges reported taking "smart drugs" for academic purposes at least once in their studies.

A lot of different terms, such as "smart pills", neuroenhancers, cognitive-enhancing substances, brain-enhancing drugs, and "brain steroids" have been recently used to describe nootropics and there is definitely a lot talk about the cognitive benefits that they provide.

The Internet is buzzing about these brain enhancing drugs as evidenced by growing media coverage in various media outlines such as BBC News, popular magazines like Men's Health as well as forums. With 150k subscribers, nootropics is definitely a "hot" topic among the brain hackers that gather on the reddit nootropics forum to ask questions, discuss the latest research, and share product reviews, including best sellers for cognitive enhancement.

Growing nootropics market provides healthier alternatives to prescription drugs. Some available through under research umbrella and some are formulations of main stream over the counter supplements. One of which is ThoughtFoods. ThoughtFoods is a reputable nootropics company that was started by Cambridge scientists studying methods to improve cognitive function in 2013. Alongside other big companies like Nootropics Depot, ThoughtFoods is one of the top players on the nootropics market selling the highest quality nootropic compounds and formulas in UK and US. There are a lot of different nootropics that have slightly different benefits, so it is difficult to have the top 5 as it very much depends on your personal needs. That said, some of the most popular research status nootropics are piracetam, aniracetam, adrafinil and tianeptine.

Piracetam is the original and well-researched nootropic, which is used to boost memory, improve focus, enhance learning, heighten immune system and even better one's personality. It is the most popular nootropic, which is believed to have started nootropics craze around the world. Aniracetam is another racetam nootropic with excellent creativity enhancing properties. Other benefits following the use of Aniracetam include enhanced memory and reduced anxiety. Adrafinil is a synthetic nootropic that belongs to the eugeroic family and is often used as an excellent alternative to the aforementioned Modafinil. It promotes alertness and wakefulness so it is a great nootropic for anyone who requires a lot of mental energy. Tianeptine is a popular nootropic compound to reduce anxiety and improve mood.

ThoughtFoods continues to be at the forefront of innovation when it comes to developing a superbly effective nootropic stacks, formulas and even drinks. One of such products is called iQuzil - the learning and productivity accelerator, which helps to improve a range of cognitive processes such as learning, memory and focus. These benefits make it an excellent choice for students. Just like another popular nootropic supplement Alpha Brain by Onnit, iQuzil is aimed at healthy individuals looking to improve their cognitive functions. iQuzil has received a lot of positive reviews and feedback.

Additionally, since the release of iQuzil more similar type of nootropic supplements have been developed by other companies. For instance, Neurohacker Collective designed their Qualia formula nootropics for focus, clarity and memory.

However, one nootropic innovation that was lacking until very recently is having all of the effective nootropics in one "smart" drink. Not long ago, iQtropics company launched a new generation nootropic smart drink called iQtonic – Think in a Drink. iQtropics CEO Kestutis Rasimavicius has a clear vision of iQtonic starting a new revolution of replacing the traditional energy drinks and becoming a convenient drink for everyone.

Thanks to their wide ranging cognitive enhancing properties, nootropics are spreading across all sectors of society and may soon even become as common as coffee. This means that people that are not using them will be left behind.

SOURCE ThoughtFoods

Related Links

http://thoughtfoods.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.